HYBRID EVENT: You can participate in person at Port of Spain, Trinidad and Tobago or Virtually from your home or work

Tentative Program

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 9–10 January 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 2 SDGs SDGs 3 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

9 JAN 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Systems Pharmacology
    39
    Track Overview

    This track will explore the latest methodologies and technologies in systems pharmacology, emphasizing their application in drug discovery and development. Participants will discuss case studies that highlight the integration of computational tools in understanding drug-target interactions.

    Track 02
    Network Biology and Drug-Target Interactions
    39
    Track Overview

    This session focuses on the role of network biology in elucidating drug-target interactions and their implications for therapeutic strategies. Researchers will present novel insights into how network dynamics influence drug efficacy and safety.

    Track 03
    Pathway Analysis in Drug Development
    39
    Track Overview

    This track will cover innovative approaches to pathway analysis in the context of drug development, highlighting the significance of signaling pathways in therapeutic optimization. Attendees will engage in discussions on the integration of pathway data with experimental findings.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Computational Modeling in Pharmacokinetics and Pharmacodynamics
    39
    Track Overview

    This session will delve into the application of computational modeling techniques in understanding pharmacokinetics and pharmacodynamics. Experts will share their experiences in developing predictive models that enhance drug efficacy and minimize adverse effects.

    Track 05
    Multi-Omics Integration for Precision Medicine
    39
    Track Overview

    This track will focus on the integration of multi-omics data to advance precision medicine initiatives. Participants will discuss methodologies for combining genomic, proteomic, and metabolomic data to identify biomarkers and therapeutic targets.

    Track 06
    Molecular Networks in Disease Mechanisms
    39
    Track Overview

    This session will explore the role of molecular networks in understanding disease mechanisms and progression. Researchers will present findings on how network perturbations can inform therapeutic interventions and biomarker discovery.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

10 JAN 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Predictive Modeling in Therapeutic Optimization
    39
    Track Overview

    This track will highlight the use of predictive modeling techniques to optimize therapeutic strategies in clinical settings. Discussions will center around case studies that demonstrate the impact of predictive analytics on treatment outcomes.

    Track 08
    Biomarker Identification through Network Pharmacology
    39
    Track Overview

    This session will focus on the identification of biomarkers using network pharmacology approaches. Participants will share insights on how network-based strategies can enhance the discovery of predictive biomarkers for various diseases.

    Track 09
    Integrative Biology in Drug Discovery
    39
    Track Overview

    This track will examine the principles of integrative biology and its application in drug discovery processes. Researchers will discuss how integrating diverse biological data can lead to novel therapeutic insights and improved drug design.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Polypharmacology and Therapeutic Strategies
    39
    Track Overview

    This session will explore the concept of polypharmacology and its implications for developing multi-target therapeutic strategies. Experts will discuss how understanding polypharmacological interactions can lead to more effective treatments for complex diseases.

    Track 11
    Signaling Pathways in Systems Medicine
    39
    Track Overview

    This track will focus on the role of signaling pathways in systems medicine, emphasizing their importance in understanding disease networks. Participants will share research that illustrates how signaling pathways can be targeted for therapeutic benefit.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 9 Industry, Innovation and Infrastructure

Be Part of ICSPNB-27

Submit your research or complete your conference registration.